Morocco, SIGA Technologies and TPOXX
CHICAGO (Reuters) - U.S. health officials have identified a cluster of cases caused by an mpox variant that are resistant to ...
Yesterday, SIGA Technologies, makers of the antiviral drug TPOXX (tecovirimat), announced that it has received $13 million in procurement orders for the drug, including two new international ...
U.S. health officials discovered a drug-resistant mpox variant in five states, prompting calls for increased surveillance.
Jay Varma, who came under fire earlier this month for admitting to hosting nude gatherings during the pandemic, shared the ...
The team at Oxford University behind the landmark RECOVERY trial of COVID-19 therapies now has monkeypox in its sights, with a study that will see if Siga Technologies' smallpox drug Tpoxx can be ...
Biopharmaceutical company, Siga Technologies (SIGA.O) has made its first commercial sale of its mpox therapy in Africa, supplying the antiviral treatment Tpoxx to Morocco, Reuters reported. This ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...
An Indian-origin former New York City senior health advisor was sacked from his job at a pharmaceutical firm recently after ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback